A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women

Climacteric

Volumn 10, Issue 4, 2007, Pages 320-334

  Sator, P G ^a,c   Sator, M O ^b   Schmidt, J B ^a   Nahavandi, H ^c   Radakovic, S ^a   Huber, J C ^b   Honigsmann H ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Hormone replacement therapy; Postmenopausal women; Skin aging; Skin thickness

Indexed keywords

DYDROGESTERONE PLUS ESTRADIOL;

ADULT; AGING; ANALYTIC METHOD; ARTICLE; CLIMACTERIUM; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CUTANEOUS PARAMETERS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; ELASTICITY; FEMALE; HAIR LOSS; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MANDIBLE; MASTOIDITIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN SURFACE; SKINFOLD THICKNESS; URTICARIA; VAGINA BLEEDING;

ADMINISTRATION, ORAL; ADULT; DERMATOLOGY; DOUBLE-BLIND METHOD; DYDROGESTERONE; ELASTICITY; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LIPIDS; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; SEBUM; SKIN AGING; SKIN PHYSIOLOGY; TELANGIECTASIS;

EID: 34547216488     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130701444073     Document Type: Article

References (30)

1. Zouboulis CC, Boschnakow A. Chronological ageing and photoaging of the human sebaceous gland. Clin Exp Dermatol 2001;26:600-7
2. Kligman AM, Koblenzer C. Demographics and psychological implications for the aging population. Dermatol Clin 1997;15:549-53
3. Brincat MP. Hormone replacement therapy and the skin. Maturitas 2000;35:107-17
4. Raine-Fenning NJ, Brincat MP, Muscat-Baron Y. Skin aging and menopause: implications for treatment. Am J Clin Dermatol 2003;4:371-8
5. Schmidt JB, Lindmaier A, Spona J. Hormone receptors in pubic skin of premenopausal and postmenopausal females. Gynecol Obstet Invest 1990;30:97-100
6. Savvas M, Bishop J, Laurent G, Watson N, Studd J. Type III collagen content in the skin of postmenopausal women receiving oestradiol and testosterone implants. Br J Obstet Gynaecol 1993;100:154-6
7. Shuster S, Black M, McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol 1985;93:639-43
8. Holland EF, Studd JW, Mansell JP, Leather AT, Bailey AJ. Changes in collagen composition and cross-links in bone and skin of osteoporotic postmenopausal women treated with percutaneous estradiol implants. Obstet Gynecol 1994;83:180-3
9. Dunn LB, Damesyn M, Moore AA, Reuben DB, Greendale GA. Does estrogen prevent skin aging? Results from the first national health and nutrition examination survey (NHANES I). Arch Dermatol 1997;133:339-42
10. Sator P-G, Schmidt JB, Sator MO, Huber JC, Hoenigsmann H. The influence of hormone replacement therapy on skin aging. A pilot study. Maturitas 2001;39:43-55
11. Oikarinen A. Systemic estrogens have no conclusive beneficial effect on human skin connective tissue. Acta Obstet Gynecol Scand 2000;79:250-4
12. Callens A, Vaillant L, Lecomte P, Berson M, Gall Y, Lorette G. Does hormonal skin aging exist? A study of the influence of different hormone therapy regimes on the skin of postmenopausal women using non-invasive measurement techniques. Dermatology 1996;193:289-94
13. Sator P-G, Schmidt JB, Hönigsmann H. Objective assessment of photoaging effects using highfrequency ultrasound in PUVA-treated psoriasis patients. Br J Dermatol 2002;147:291-8
14. Sumino H, Ichikawa S, Abe M, Endo Y, Ishikawa O, Kurabayashi M. Effects of aging, menopause, and hormone replacement therapy on forearm skin elasticity in women. J Am Geriatr Soc 2004;52:945-9
15. Tsukahara K, Nakagawa H, Moriwaki S, et al. Ovariectomy is sufficient to accelerate spontaneous skin aging and to stimulate ultraviolet irradiation-induced photoaging of murine skin. Br J Dermatol 2004;151:984-94
16. Braverman IM, Fonferko E. Studies in cutaneous aging. I. The elastic fiber network. J Invest Dermatol 1982;78:434-43
17. Pochi PE, Kligman AM. The effects of androgens and estrogens on human sebaceous glands. J Invest Dermatol 1962;39:139-55
18. Pierard GE. The quandary of climacteric skin aging. Dermatology 1996;193:273-4
19. Grosman N, Heridbey E, Schon J. The effect of estrogenic treatment on the acid mucopolysaccharide pattern in the skin of mice. Acta Pharmacol Toxicol 1971;30:458-64
20. Jemec GBE, Serup J. Short-term effects of topical 17β-oestradiol on human postmenopausal skin. Maturitas 1989;11:229-34
21. Punnonen R, Rauramo L. Effect of estrogen therapy on climacteric symptoms and tissue changes. Acta Obstet Gynecol Scand 1974;53:267-9
22. Brincat M, Moniz CJ, Studd JWW, et al. Long-term effects of menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 1985;92:256-9
23. Brincat MP, Muscat Baron Y, Galea R. Estrogens and the skin. Climacteric 2005;8:110-23
24. Haapasaari K-M, Raudakoki T, Kailloinen M, et al. Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women. Maturitas 1997;27:153-62
25. Punnonen R. On the effect of castration and peroral estrogen therapy on the skin. Acta Obstet Scand Suppl 1971;9(Suppl 9):32
26. Urano R, Sakabe K, Seiki K, Ohkido M. Female sex hormone stimulates cultured human keratinocyte proliferation and its RNA and proteinsynthetic activities. J Dermatol Sci 1995;9:176-84
27. Ashcroft GS, Dodsworth J, Van Boxtel E, et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 1997;3:1209-15
28. Kanda N, Watanabe S. 17β-Estradiol stimulates the growth of human keratinocytes by inducing cyclin D2 expression. J Invest Dermatol 2004;123:319-28
29. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative (WHI) randomized controlled trial. JAMA 2002;288:321-33
30. Beral V, Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003;362:419-27